Benjamin Maimon (co-founder) is a PhD student at the Massachusetts Institute of Technology, pursuing a degree in Medical Engineering & Medical Physics from the Harvard-MIT Health Sciences and Technology program. Ben has extensive design experience at Medtronic and iRhythm. He also has management consulting experience, conducting due diligence analyses for acquisitions as an analyst at the private equity practice of Dean & Co. Benjamin graduated from Duke University with a bachelor’s degree in Mechanical Engineering and Biomedical Engineering.
Christopher Lee (co-founder) is a PhD student at Harvard Medical School and the Massachusetts Institute of Technology, within the joint Harvard-MIT Health Sciences and Technology program. Chris has a master's degree in Bioengineering Innovation and Design from Johns Hopkins University. He has management consulting experience from his time at Sagentia, as well as experience working in venture capital with RA Capital Management. Chris is a Forbes 30 under 30, World Economic Forum Global Shaper, and Boston MedTech 40 under 40.
Ho-Jun is currently a Medical Engineering & Medical Physics PhD student in the Harvard-MIT Health Sciences and Technology program. Ho-Jun’s prior research and industry experiences span from high-power LED development to dielectrophoresis-based mammalian cell manipulation to biosensors for detection of pathogenic bacteria. Prior to Recon Therapeutics, Ho-Jun spent nearly two years working for one of the world’s leading LED suppliers, Seoul Semiconductor Co., LTD, where he designed and developed novel high-power LED chips. He also worked at a government-run research institute in Korea for 1.5 years, focusing on the development of low-cost, easy-to-use biosensors for rapid detection of bacteria that cause food poisoning. Ho-Jun has been awarded numerous fellowships and research awards for his achievements, including Samsung Scholarship and Undergraduate Research Awards.
Jack Aguilar is currently a medical student at the Geisel School of Medicine at Dartmouth. He is also a William J. von Liebig (renamed T35) Fellow at the Vascular Surgery Division of Beth Israel Deaconess Medical Center, and a Clinical Innovation Intern at the Healthcare Transformation Lab at Massachusetts General Hospital. He has a degree in Biomedical Engineering from Johns Hopkins University. Jack has start-up experience, having co-founded a diagnostic device for HIV, Hep B and Hep C, and he has work experience as an analyst at Accenture and intern at Avalere Health LLC.